- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00969280
Acupuncture for Dry Eye Syndrome
Acupuncture for Dry Eye Syndrome : A Randomized, Patient-Assessor Blinded, Non-acupuncture Point Shallow Penetration-Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Chongchungdo
-
Daejeon, Chongchungdo, Korea, Republic of, 302-869
- Clinical Research Center, Korea institute of oriental medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients who have had dry eye syndromes in single eye or in both eyes e.g. Other disorders of lacrimal gland: Dry eye syndrome (ICD-10: H04.1). He or she must have both of the conditions below:
- Patients who have had such symptoms like ocular itching, ocular foreign body sensation, ocular burning, ocular pain, ocular dryness, blurred vision, sensation of photophobia, ocular redness, sensation of tearing
- Patient whose tear film break-up time (BUT) is below 10 seconds and measured tear amount is below 10mm/5sec by Schirmer 1 test
Exclusion Criteria:
- Those who have defects of eyelid or eyelashes
- Those who have acute infection of eyelid, eyeball or accessories of eye
- Those who have Stevens-Johnson syndromes or Pemphigoids
- Those who have Vitamin A deficiency
- Those who have any defects of eye or accessories of eye by external injuries
- Those who have undergone any surgical operation for eye during last 3 months
- Those who are using contact lens
- Those who have any difficulties about eye opening or eye closing due to facial palsy
- Those who have undergone punctual occlusion surgery
- Those who have used any kinds of anti-inflammatory eyedrops for recent 2 weeks (steroids, cyclosporin or autologous serum eyedrops)
- Those who have systemic immune therapy
- Those who are pregnant or have any plan for pregnancy
- Those who are not appropriate to this study by investigators decision
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Standardized Acupuncture group
|
Acupuncture treatment will be applied 3 times per week, total 9 times for 3 weeks. According to the guideline of WHO standard acupuncture point locations in the western pacific region, acupuncture treatment will be offered in all 17 acupoints: both BL2, GB14, TE23, Extra-1(Taiyang), ST1 and GB 20, and GV23, and Left SP3, LU9, LU10 and HT8, which are located in periorbit, forehead or temple of the head and Lt. forearm and back of the Lt. foot by a disposable 20*30mm (Dongbang Co., korea) acupuncture needle. All the acupuncture needles will be inserted, induced strong 'deqi' sensation and retained for 20 minutes. |
|
PLACEBO_COMPARATOR: Non-acupoint shallow penetration group
|
Acupuncture treatment will be applied 3 times per week, all 9 times for 3 weeks. Acupuncture treatment will be offered in 17 non-acupuncture points by a disposable 20*30mm acupuncture needle. A strong 'deqi' sensation will not be induced, but inserted acupunctures will be leaved for 20 minutes. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ocular Surface Disease Index : OSDI
Time Frame: Visit 11 (after 3 weeks from baseline)
|
The OSDI is a questionnaire that consists of 12 questions about ocular irritation and the effect of dry eye on vision.
For every question, participants checked at a score between 0 and 4, where 0 equals "none of the time" and 4 equals "all of the time".
OSDI scores will be calculated according to the following formula: OSDI = [(sum of scores for all questions answered)*100] / [(total number of questions answered)*4].
The possible range of the OSDI score is 0 to 100.
Mean difference of the OSDI scores was calculated from the OSDI scores between Visit 11 and baseline.
|
Visit 11 (after 3 weeks from baseline)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Visual Analogue Scale of Self Symptoms
Time Frame: every visit
|
every visit
|
|
Schirmer 1 Test
Time Frame: visit 1,10
|
visit 1,10
|
|
Tear Film Break-up Time : BUT
Time Frame: Visit 1, 10
|
Visit 1, 10
|
|
Medication Quantification Scale (MQS)
Time Frame: every visit
|
every visit
|
|
General Assessment
Time Frame: visit 11
|
visit 11
|
Collaborators and Investigators
Investigators
- Study Director: Sunmi Choi, doctor, Korea Institute of Oriental Medicine
- Principal Investigator: Taehun Kim, Doctor, Korea Institute of Oriental Medicine
- Principal Investigator: Mi-suk Shin, Master, Korea Institute of Oriental Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KI0906
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Syndromes
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
Neuro-Ophthalmology of TexasHarrow IncRecruiting
-
Vision Innovation Centers of Pennsylvania, LLC...Nordic Pharma, USARecruiting
-
Demaod LtdNot yet recruitingDry Eye | Dry Eye Syndromes
-
Eye & ENT Hospital of Fudan UniversityRecruiting
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
Clinical Trials on Standardized Acupuncture
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Dongwoo NamGachon University Gil Medical Center; Ministry of Health & Welfare, KoreaUnknownEfficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Low Back PainLow Back PainKorea, Republic of
-
Chengdu PLA General HospitalUnknownLow Back Pain | Ankylosing SpondylitisChina
-
Westlake UniversityHangzhou Maternal and Child Health HospitalActive, not recruitingDiabetes, Gestational | Pregnancy in Diabetics | Intrauterine HyperglycemiaChina
-
Liu QiangZhejiang Provincial People's Hospital; The Third Affiliated hospital of Zhejiang... and other collaboratorsNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Myocardial Revascularization
-
United States Naval Medical Center, San DiegoUniversity of California, San Francisco; TriService Nursing Research ProgramCompletedPerceived StressUnited States
-
Matthew SnyderCompletedPain, Postoperative | Acupuncture | VasectomyUnited States
-
BiomeHub Biotechnology CompanyRecruitingGlucose Metabolism Disorders | Diabetes | Health Behavior | Metabolic DiseaseBrazil
-
Westlake UniversityWenzhou People's HospitalRecruitingGestational Diabetes Mellitus | Nutrition, Healthy | Intrauterine Hyperglycemia | Birth Outcome, AdverseChina
-
National Taiwan University HospitalEnrolling by invitationEducation, MedicalTaiwan